Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of <scp><i>KRAS</i></scp> statusJunko Kato, Kazuhiro Yoshida|International Journal of Cancer|2015Cited by 17